Farrer MJ - Search Results

1

Defining neurodegeneration on Guam by targeted genomic sequencing.

Steele JC, Guella I, Szu-Tu C, Lin MK, Thompson C, Evans DM, Sherman HE, Vilariño-Güell C, Gwinn K, Morris H, Dickson DW, Farrer MJ. Steele JC, et al. Among authors: farrer mj. Ann Neurol. 2015 Mar;77(3):458-68. doi: 10.1002/ana.24346. Epub 2015 Feb 3. Ann Neurol. 2015. PMID: 25558820

2

Low frequency of alpha-synuclein mutations in familial Parkinson's disease.

Farrer M, Wavrant-De Vrieze F, Crook R, Boles L, Perez-Tur J, Hardy J, Johnson WG, Steele J, Maraganore D, Gwinn K, Lynch T. Farrer M, et al. Ann Neurol. 1998 Mar;43(3):394-7. doi: 10.1002/ana.410430320. Ann Neurol. 1998. PMID: 9506559

3

Pathology of PD in monozygotic twins with a 20-year discordance interval.

Dickson D, Farrer M, Lincoln S, Mason RP, Zimmerman TR Jr, Golbe LI, Hardy J. Dickson D, et al. Neurology. 2001 Apr 10;56(7):981-2. doi: 10.1212/wnl.56.7.981. Neurology. 2001. PMID: 11294946 No abstract available.

4

Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications.

Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, Langston JW. Farrer M, et al. Ann Neurol. 2004 Feb;55(2):174-9. doi: 10.1002/ana.10846. Ann Neurol. 2004. PMID: 14755720

5

Autosomal dominant parkinsonism associated with variable synuclein and tau pathology.

Wszolek ZK, Pfeiffer RF, Tsuboi Y, Uitti RJ, McComb RD, Stoessl AJ, Strongosky AJ, Zimprich A, Müller-Myhsok B, Farrer MJ, Gasser T, Calne DB, Dickson DW. Wszolek ZK, et al. Among authors: farrer mj. Neurology. 2004 May 11;62(9):1619-22. doi: 10.1212/01.wnl.0000125015.06989.db. Neurology. 2004. PMID: 15136696

6

Genome-wide analysis of the parkinsonism-dementia complex of Guam.

Morris HR, Steele JC, Crook R, Wavrant-De Vrièze F, Onstead-Cardinale L, Gwinn-Hardy K, Wood NW, Farrer M, Lees AJ, McGeer PL, Siddique T, Hardy J, Perez-Tur J. Morris HR, et al. Arch Neurol. 2004 Dec;61(12):1889-97. doi: 10.1001/archneur.61.12.1889. Arch Neurol. 2004. PMID: 15596609

7

Tau kinases and Parkinson's disease: guilt by association?

Dickson DW, Farrer MJ. Dickson DW, et al. Among authors: farrer mj. Ann Neurol. 2005 Dec;58(6):819-20. doi: 10.1002/ana.20764. Ann Neurol. 2005. PMID: 16315283 No abstract available.

8

Lrrk2 and Lewy body disease.

Ross OA, Toft M, Whittle AJ, Johnson JL, Papapetropoulos S, Mash DC, Litvan I, Gordon MF, Wszolek ZK, Farrer MJ, Dickson DW. Ross OA, et al. Among authors: farrer mj. Ann Neurol. 2006 Feb;59(2):388-93. doi: 10.1002/ana.20731. Ann Neurol. 2006. PMID: 16437559

9

Clinical and pathologic features of families with LRRK2-associated Parkinson's disease.

Whaley NR, Uitti RJ, Dickson DW, Farrer MJ, Wszolek ZK. Whaley NR, et al. Among authors: farrer mj. J Neural Transm Suppl. 2006;(70):221-9. doi: 10.1007/978-3-211-45295-0_34. J Neural Transm Suppl. 2006. PMID: 17017533 Review.

10

Parkinsonism, Lrrk2 G2019S, and tau neuropathology.

Rajput A, Dickson DW, Robinson CA, Ross OA, Dächsel JC, Lincoln SJ, Cobb SA, Rajput ML, Farrer MJ. Rajput A, et al. Among authors: farrer mj. Neurology. 2006 Oct 24;67(8):1506-8. doi: 10.1212/01.wnl.0000240220.33950.0c. Neurology. 2006. PMID: 17060589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters